EP0994858 - 2-SUBSTITUTED IMIDAZOLES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 12.01.2007 Database last updated on 05.07.2024 | Most recent event Tooltip | 12.01.2007 | Application deemed to be withdrawn | published on 14.02.2007 [2007/07] | Applicant(s) | For all designated states Ortho-McNeil Pharmaceutical, Inc. U.S. Route No. 202, P.O. Box 300 Raritan, NJ 08869-0602 / US | [N/P] |
Former [2000/17] | For all designated states Ortho-McNeil Pharmaceutical, Inc. U.S. Route No.202, P.O. Box 300 Raritan, NJ 08869-0602 / US | Inventor(s) | 01 /
WACHTER, Michael 52 North Street Bloomsbury, NJ 08804 / US | 02 /
BEERS, Scott, A. 11 Kirkride Road Flemington, NJ 08822 / US | 03 /
MALLOY, Elizabeth 8 Canterberry Circle Flemington, NJ 08822 / US | 04 /
WU, Wei 149 West End Avenue Somerville, NJ 08876 / US | [2000/33] |
Former [2000/17] | 01 /
WACHTER, Michael 52 North Street Bloomsbury, NJ 08804 / US | ||
02 /
BEERS, Scott, A. 11 Kirkride Road Flemington, NJ 08822 / US | Representative(s) | Mercer, Christopher Paul, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
Former [2000/17] | Mercer, Christopher Paul, et al Carpmaels & Ransford 43, Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 98939071.1 | 29.06.1998 | [2000/17] | WO1998US13419 | Priority number, date | US19970051301P | 30.06.1997 Original published format: US 51301 P | [2000/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9903837 | Date: | 28.01.1999 | Language: | EN | [1999/04] | Type: | A1 Application with search report | No.: | EP0994858 | Date: | 26.04.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.01.1999 takes the place of the publication of the European patent application. | [2000/17] | Search report(s) | International search report - published on: | EP | 28.01.1999 | Classification | IPC: | C07D233/54, C07D233/84, C07D401/04, A61K31/415, A61K31/44 | [2000/17] | CPC: |
C07D401/04 (EP,US);
C07D233/54 (KR);
A61P19/02 (EP);
A61P19/10 (EP);
A61P29/00 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/17] | Title | German: | ZUR BEHANDLUNG VON ENTZÜNDLICHEN KRANKHEITEN VERWENDBARE 2-SUBSTITUIERTE IMIDAZOLE | [2000/17] | English: | 2-SUBSTITUTED IMIDAZOLES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | [2000/17] | French: | IMIDAZOLES SUBSTITUEES EN 2 UTILISABLES POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES | [2000/17] | Entry into regional phase | 20.01.2000 | National basic fee paid | 20.01.2000 | Designation fee(s) paid | 20.01.2000 | Examination fee paid | Examination procedure | 21.01.1999 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 20.01.2000 | Examination requested [2000/17] | 16.04.2002 | Despatch of a communication from the examining division (Time limit: M06) | 10.02.2003 | Reply to a communication from the examining division | 27.04.2004 | Despatch of a communication from the examining division (Time limit: M06) | 11.02.2005 | Reply to a communication from the examining division | 16.02.2006 | Despatch of a communication from the examining division (Time limit: M06) | 29.08.2006 | Application deemed to be withdrawn, date of legal effect [2007/07] | 29.09.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/07] | Request for further processing for: | 11.02.2005 | Request for further processing filed | 11.02.2005 | Full payment received (date of receipt of payment) Request granted | 24.02.2005 | Decision despatched | 10.02.2003 | Request for further processing filed | 10.02.2003 | Full payment received (date of receipt of payment) Request granted | 26.02.2003 | Decision despatched | Fees paid | Renewal fee | 20.01.2000 | Renewal fee patent year 03 | 13.06.2001 | Renewal fee patent year 04 | 12.06.2002 | Renewal fee patent year 05 | 12.06.2003 | Renewal fee patent year 06 | 14.06.2004 | Renewal fee patent year 07 | 14.06.2005 | Renewal fee patent year 08 | 14.06.2006 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]JPS6293278 ; | [Y]JPS6310767 ; | [Y]JPS63239274 ; | [X]DE2635876 (DU PONT) [X] 1,12 * page 3, line 1 - line 11 * * see page 35, examples 26,28,33,34,35,36;; claims 1,18 *; | [X]DE2805167 (DU PONT) [X] 1,12 * page 7, line 1 * * page 26, line 30 - line 31 * * page 30, line 15 * * claims 1,14 *; | [X]DE2805166 (DU PONT) [X] 1,12 * page 9, line 1 * * see page 33, first compound;; claims 1,16 *; | [X]EP0004648 (CIBA GEIGY AG [CH]) [X] 1,12 * see example 1, first paragraph; example 4, third and sixth compound; example 5, compound "2-Propylthio-4(5)-phenyl-5(4)- (3-pyridyl)-imidazol"; page 5 *; | [X]DE2823197 (SCHERING AG) [X] 1,12 * claims 16,19,22,25,55,56 *; | [X]US4190666 (CHERKOFSKY SAUL C [US], et al) [X] 1,12 * see table I, examples 26,28,33,34,35,36 * * claims 1,29 *; | [X]DE2856909 (SCHERING AG) [X] 1,12 * claims 30,33,36,37,42,43 *; | [Y]EP0032113 (DU PONT [US]) [Y] 1,12 * claims 1,8; table 1 *; | [Y]EP0043788 (SCHERING AG [DE]) [Y] 1,12 * see page 6, compound no. VI * * claims 1,16 *; | [Y]US4330552 (CHERKOFSKY SAUL C) [Y] 1,12 * claims 1,2; table - *; | [X]US4348404 (WHITNEY JOEL G) [X] 1,12 * see columns 7, 8 table I, examples 2,4,7,8,9,13,14,15,16,17,18,22;; claims 1,10 *; | [X]US4372964 (WHITNEY JOEL G) [X] 1 * see table 4, example 41 * * claims 1,10 *; | [X]AT374198B (CIBA GEIGY AG [CH]) [X] 1 * see starting compound of example 1 * * page 11, line 9 * * page 11, line 20 *; | [X]WO8801167 (SMITHKLINE BECKMAN CORP [US]) [X] 1,12 * see page 8, compound no. 1;; claim 1 *; | [X]WO9204330 (SMITH KLINE FRENCH LAB [GB]) [X] 1 * see the starting compounds of the following examples: 1,4,6,7,20,28,29,32 *; | [X]EP0522887 (RHONE POULENC RORER LTD [GB]) [X] 1 * page 8, line 30 *; | [DX]WO9314081 (SMITHKLINE BEECHAM CORP [US]) [DX] 1-3,12 * page 40, line 14 - line 15; claims 1,13,14 *; | [PX]US5656644 (ADAMS JERRY LEROY [US], et al) [PX] 1,12 * column 5, line 36 - line 49 * * column 12, line 65 * * column 13, line 16 - line 17 * * column 14, line 66 - line 67 * * claims 1,11 *; | [XY] - PATENT ABSTRACTS OF JAPAN, (19870929), vol. 11, no. 300, Database accession no. (C - 449), & JP62093278 A 19870428 (YOSHITOMI PHARMACEUT IND LTD) [XY] 1,12 * abstract * | [Y] - PATENT ABSTRACTS OF JAPAN, (19880617), vol. 12, no. 213, Database accession no. (C - 505), & JP63010767 A 19880118 (YOSHITOMI PHARMACEUT IND LTD) [Y] 1,12 * abstract * | [Y] - PATENT ABSTRACTS OF JAPAN, (19890130), vol. 13, no. 42, Database accession no. (C - 564), & JP63239274 A 19881005 (TOYAMA CHEM CO LTD) [Y] 1,12 * abstract * | [A] - J. P. WHITTEN ET AL., JOURNAL OF ORGANIC CHEMISTRY, (1986), vol. 51, pages 1891 - 4, XP002082708 [A] 1 DOI: http://dx.doi.org/10.1021/jo00360a044 | [A] - B. H. LIPSHUTZ ET AL., TETRAHEDRON LETTERS, (1986), vol. 27, no. 35, pages 4095 - 8, XP002082709 [A] 1 DOI: http://dx.doi.org/10.1016/S0040-4039(00)84919-9 |